Javascript must be enabled to continue!
Tet2-mediated macrophage activation promotes liver regeneration
View through CrossRef
Abstract
Objective Macrophages are predominant immune cells that secret IL-6 and HGF to promote liver regeneration after liver resection. Ten-eleven translocation- 2 (Tet2) DNA dioxygenase regulates the secretion of pro-inflammatory factors in macrophages. In this study, we explored the role of Tet2 in macrophages and its function independent of its enzymatic activity in liver regeneration.
Methods A 70% partial hepatectomy mice model was established. Enzyme-linked immunosorbent assays, quantitative reverse transcription-polymerase chain reaction, western blotting, immunofluorescences, and flow cytometry were performed to explore the infiltration and phenotypes of immune cells in mice models. Molecular dynamics simulations were carried out to study the interaction of Tet2 with Stat1.
Results We found Tet2 in macrophages negatively regulates liver regeneration in the partial hepatectomy mice model. In mechanism, Tet2 interacts with Stat1 to inhibit the expressions of proinflammatory factors and suppress liver regeneration. Tet2 inhibitor BC339 attenuated the interaction of Stat1 and Tet2, enhanced Stat1 phosphorylation, and promoted hepatocyte proliferation. Notably, Tet2 also directly affected hepatocyte proliferation, independent of the IL-6-Stat3 signaling pathway.
Conclusion Tet2 in macrophages negatively regulates liver regeneration via interacting with Stat1. Our results suggest that specific targeting Tet2 in macrophages promotes the recovery of liver function after hepatectomy. Keywords Macrophage, Liver regeneration, partial hepatectomy, Tet2.
Research Square Platform LLC
Title: Tet2-mediated macrophage activation promotes liver regeneration
Description:
Abstract
Objective Macrophages are predominant immune cells that secret IL-6 and HGF to promote liver regeneration after liver resection.
Ten-eleven translocation- 2 (Tet2) DNA dioxygenase regulates the secretion of pro-inflammatory factors in macrophages.
In this study, we explored the role of Tet2 in macrophages and its function independent of its enzymatic activity in liver regeneration.
Methods A 70% partial hepatectomy mice model was established.
Enzyme-linked immunosorbent assays, quantitative reverse transcription-polymerase chain reaction, western blotting, immunofluorescences, and flow cytometry were performed to explore the infiltration and phenotypes of immune cells in mice models.
Molecular dynamics simulations were carried out to study the interaction of Tet2 with Stat1.
Results We found Tet2 in macrophages negatively regulates liver regeneration in the partial hepatectomy mice model.
In mechanism, Tet2 interacts with Stat1 to inhibit the expressions of proinflammatory factors and suppress liver regeneration.
Tet2 inhibitor BC339 attenuated the interaction of Stat1 and Tet2, enhanced Stat1 phosphorylation, and promoted hepatocyte proliferation.
Notably, Tet2 also directly affected hepatocyte proliferation, independent of the IL-6-Stat3 signaling pathway.
Conclusion Tet2 in macrophages negatively regulates liver regeneration via interacting with Stat1.
Our results suggest that specific targeting Tet2 in macrophages promotes the recovery of liver function after hepatectomy.
Keywords Macrophage, Liver regeneration, partial hepatectomy, Tet2.
Related Results
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED]Product Name - Bridport Health Ingredients - Milk Thistle, Beetroot, Artichoke Extract & More. Category - Liver Support Supplement Main Benefits - Helps Protect The ...
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED]Depiction • Where to Get Bottle Online –Click Here • Item Name -Bridport Health Liver • Aftereffects - No Major Side Effects • Classification - Health • Accessibility -O...
High Incidence of TET2 Mutation in Chinese Patients with MDS and AML with Previous History of MDS
High Incidence of TET2 Mutation in Chinese Patients with MDS and AML with Previous History of MDS
Abstract
Abstract 4943
Myelodysplastic syndromes(MDS) are a heterogeneous group of myeloid neoplasms characterized by cytopenia, dysplasia in one or m...
Residual Wild-Type Tet2/Tet3 Allele Is the Savior Preventing Mouse Hematopoietic Progenitor Cells from Leukemia Development
Residual Wild-Type Tet2/Tet3 Allele Is the Savior Preventing Mouse Hematopoietic Progenitor Cells from Leukemia Development
Abstract
Background: Loss-of-function mutations in ten-eleven-translocation-2 (TET2) have been identified in myeloid and lymphoid malignancies. They have also been f...
Bi-allelic TET2 alterations are frequently found in NPM1 mutated AML and constitute a distinct subgroup with unfavorable prognosis
Bi-allelic TET2 alterations are frequently found in NPM1 mutated AML and constitute a distinct subgroup with unfavorable prognosis
Abstract
Background: Mutations (mut) in TET2 and NPM1 are common in myeloid neoplasms, with NPM1mut defining a distinct ...
A temporal map of gene expression pattern during zebrafish liver regeneration
A temporal map of gene expression pattern during zebrafish liver regeneration
Abstract
Background & Aims
Zebrafish is increasingly being used to study liver injury and regeneration. However, very littl...
Abstract 1130: The role of TET2 in mammary stem cell fate decision
Abstract 1130: The role of TET2 in mammary stem cell fate decision
Abstract
Epigenetic mechanisms, including DNA methylation, has an essential role in governing the stem cell fate decision. The Ten-Eleven-Translocation (TET) protein...
Abstract PO-005: Tet2 inactivation enhances the anti-tumor efficiency of tumor-infiltrating lymphocytes (TILs)
Abstract PO-005: Tet2 inactivation enhances the anti-tumor efficiency of tumor-infiltrating lymphocytes (TILs)
Abstract
Inactivation of tumor infiltrating lymphocytes (TILs) is one of the mechanisms mitigating anti-tumor immunity during tumor onset and progression. Epigenetic...

